For Islets Only


By: Daniel Trecroci

The Scripps-Whittier Diabetes Research Program at the University of California, San Diego, has announced that sometime in late 2002, it will create a new islet-research center focused on harvesting islets and transplanting them into humans. In addition, the new lab will perform research aimed at replicating islets to help solve the problem with donor shortages.

The lab will be one of only a handful of centers of its kind in the United States. Other islet-research centers currently exist in Miami, Minnesota, St Louis, Philadelphia, Boston, Seattle and at the National Institutes of Health in Bethesda, Maryland.

Under the direction of Alberto Hayek, MD, the Whittier Islet and Transplantation and Research Center will follow the transplant procedures of the revolutionary Edmonton Protocol, which involves transplanting cells into patients immediately after removal from a donor pancreas. By doing this, islets remain fresh, thus eliminating the need for steroids. To protect the transplanted islets from rejection using this protocol, the patients are then put on anti-rejection drugs.

According to a recent Scripps-Whittier newsletter, 14 of 17 people receiving the Edmonton Protocol procedure have maintained normal blood-sugars levels after one year without taking insulin shots.



Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.